Emmaus Life Sciences, Inc. (EMMA) Reports In-Line Q2 EPS

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $10.76 million versus the consensus estimate of $5 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
• Home Depot beats estimates, reaffirms fiscal 2026 guidance